Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:Recurrence
go back to main search page
Accession:DOID:9002801 term browser browse the term
Definition:The return of a sign, symptom, or disease after a remission.
Synonyms:exact_synonym: Recrudescence;   Recrudescences;   Recurrences;   Relapse;   Relapses
 primary_id: MESH:D012008;   RDO:0006465
For additional species annotation, visit the Alliance of Genome Resources.


show annotations for term's descendants       view all columns           Sort by:
 
Recurrence term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Atp7a ATPase copper transporting alpha JBrowse link X 77,076,085 77,193,644 RGD:11554173
G Ccne1 cyclin E1 JBrowse link 1 94,485,830 94,495,112 RGD:11554173
G Cd274 CD274 molecule JBrowse link 1 247,519,890 247,539,659 RGD:11554173
G Chd5 chromodomain helicase DNA binding protein 5 JBrowse link 5 169,519,212 169,572,059 RGD:11554173
G Crabp2 cellular retinoic acid binding protein 2 JBrowse link 2 187,322,416 187,326,794 RGD:11554173
G Crlf2 cytokine receptor-like factor 2 JBrowse link 14 1,456,843 1,461,543 RGD:11554173
G Cst3 cystatin C JBrowse link 3 143,219,671 143,223,544 RGD:11554173
G Cstb cystatin B JBrowse link 20 10,966,357 10,968,399 RGD:11554173
G Ctsl cathepsin L JBrowse link 17 1,873,105 1,879,266 RGD:11554173
G Cxcl12 C-X-C motif chemokine ligand 12 JBrowse link 4 149,261,044 149,273,891 RGD:11554173
G Cxcl13 C-X-C motif chemokine ligand 13 JBrowse link 14 15,253,146 15,258,221 RGD:11554173
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 JBrowse link 8 58,744,849 58,772,408 RGD:11554173
G Dock8 dedicator of cytokinesis 8 JBrowse link 1 242,934,685 243,153,472 RGD:11554173
G Eef2 eukaryotic translation elongation factor 2 JBrowse link 7 11,401,501 11,406,771 RGD:11554173
G Erbb2 erb-b2 receptor tyrosine kinase 2 JBrowse link 10 86,367,596 86,391,728 RGD:11554173
G Erbb3 erb-b2 receptor tyrosine kinase 3 JBrowse link 7 2,989,202 3,010,610 RGD:11554173
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit JBrowse link 10 2,010,140 2,037,953 RGD:11554173
G Flt1 Fms related receptor tyrosine kinase 1 JBrowse link 12 9,033,993 9,205,886 RGD:11554173
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 JBrowse link 2 200,452,623 200,480,785 RGD:11554173
G Hras HRas proto-oncogene, GTPase JBrowse link 1 214,178,404 214,181,841 RGD:11554173
G Itpa inosine triphosphatase JBrowse link 3 123,209,611 123,221,266 RGD:11554173
G Kras KRAS proto-oncogene, GTPase JBrowse link 4 179,482,562 179,515,483 RGD:11554173
G Mgmt O-6-methylguanine-DNA methyltransferase JBrowse link 1 209,237,255 209,464,189 RGD:11554173
G Mmp7 matrix metallopeptidase 7 JBrowse link 8 5,893,253 5,900,965 RGD:11554173
G Nt5c2 5'-nucleotidase, cytosolic II JBrowse link 1 266,652,966 266,782,935 RGD:11554173
G Pgr progesterone receptor JBrowse link 8 7,128,656 7,187,796 RGD:11554173
G Pomc proopiomelanocortin JBrowse link 6 28,382,937 28,388,771 RGD:11554173
G Ptpn14 protein tyrosine phosphatase, non-receptor type 14 JBrowse link 13 108,689,916 108,841,593 RGD:11554173
G Slc19a1 solute carrier family 19 member 1 JBrowse link 20 12,334,675 12,354,517 RGD:11554173
G Sult1a1 sulfotransferase family 1A member 1 JBrowse link 1 198,100,586 198,104,106 RGD:11554173
G Top1 DNA topoisomerase I JBrowse link 3 156,635,688 156,717,686 RGD:11554173
G Top2a DNA topoisomerase II alpha JBrowse link 10 86,901,467 86,930,947 RGD:11554173
G Vegfc vascular endothelial growth factor C JBrowse link 16 40,440,371 40,555,178 RGD:11554173
G Yap1 Yes1 associated transcriptional regulator JBrowse link 8 6,133,014 6,204,240 RGD:11554173

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 15849
    Pathological Conditions, Signs and Symptoms 8392
      Pathologic Processes 5449
        Disease Attributes 544
          Recurrence 34
            Symptom Flare Up 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.